Mednax Historical Income Statement

MD Stock

USD 14.21 0.06 0.42%

Historical analysis of Mednax income statement accounts such as Gross Profit of 2.1 B, Other Operating Expenses of 1.3 B or Cost Of Revenue of 1 B can show how well Mednax Inc performed in making a profits. Evaluating Mednax income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mednax's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Mednax Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mednax Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About Mednax Income Statement Analysis

Mednax Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mednax shareholders. The income statement also shows Mednax investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mednax Income Statement Chart

At present, Mednax's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Total Operating Expenses is expected to grow to about 2.2 B, whereas Total Revenue is forecasted to decline to about 1.5 B.

Total Revenue Other Operating Expenses Minority Interest Extraordinary Items

Total Revenue

Total revenue comprises all receipts Mednax Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mednax Inc. It is also known as Mednax overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Minority Interest

Minority Interest is the portion of a subsidiary corporation stock that is not owned by the parent corporation. The magnitude of the minority interest in the subsidiary company is generally less than 50% of outstanding shares, otherwise the corporation would generally cease to be a subsidiary of the parent. Minority Interest can also be called non-controlling interest.All shareholders of Mednax Inc whose combined shares represent less than 50% of the total outstanding shares issued by Mednax have a minority interest in Mednax.

Most accounts from Mednax's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mednax Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mednax Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

	2022	2023	2024	2025 (projected)
Gross Profit	467.0M	421.6M	2.0B	2.1B
Total Revenue	2.0B	2.0B	2.0B	1.5B

Gross Profit Total Revenue

Mednax income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Operating Income Net Other	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Discontinued Operations	Reconciled Depreciation	Extraordinary Items	Non Recurring
Depreciation And Amortization		0.56	0.94	0.25	0.92	0.65	0.65	0.72	0.92	-0.01	0.08	-0.22	0.03	0.23	0.95	-0.42	-0.02	0.32	0.14	-0.07	0.5	-0.38	-0.15	0.41	0.06	0.34
Interest Expense	0.56		0.58	0.06	0.65	0.1	0.1	0.16	0.65	0.02	-0.5	-0.54	-0.48	-0.47	0.72	-0.3	-0.53	0.3	0.57	-0.68	0.92	-0.71	-0.68	-0.31	-0.64	0.01
Total Revenue	0.94	0.58		0.28	0.98	0.67	0.67	0.73	0.99	0.0	-0.02	-0.34	-0.07	0.22	0.97	-0.63	-0.16	0.28	0.12	-0.17	0.49	-0.4	-0.27	0.28	-0.02	0.26
Gross Profit	0.25	0.06	0.28		0.32	-0.18	-0.18	-0.13	0.27	0.94	-0.11	-0.01	-0.11	-0.09	0.32	-0.41	-0.16	-0.38	-0.01	-0.32	0.27	0.25	0.06	-0.17	0.16	-0.3
Other Operating Expenses	0.92	0.65	0.98	0.32		0.53	0.54	0.61	1.0	0.08	-0.12	-0.37	-0.16	0.07	0.97	-0.63	-0.24	0.18	0.22	-0.31	0.55	-0.38	-0.3	0.14	-0.05	0.13
Operating Income	0.65	0.1	0.67	-0.18	0.53		1.0	0.99	0.58	-0.52	0.39	-0.1	0.3	0.71	0.55	-0.32	0.25	0.67	-0.27	0.51	-0.02	-0.4	-0.07	0.74	0.08	0.72
Ebit	0.65	0.1	0.67	-0.18	0.54	1.0		1.0	0.59	-0.51	0.39	-0.1	0.3	0.71	0.56	-0.33	0.25	0.66	-0.27	0.51	-0.02	-0.39	-0.06	0.73	0.09	0.7
Ebitda	0.72	0.16	0.73	-0.13	0.61	0.99	1.0		0.65	-0.47	0.37	-0.12	0.28	0.68	0.63	-0.35	0.23	0.65	-0.23	0.45	0.04	-0.41	-0.07	0.72	0.09	0.69
Cost Of Revenue	0.92	0.65	0.99	0.27	1.0	0.58	0.59	0.65		0.02	-0.11	-0.39	-0.15	0.1	0.97	-0.62	-0.24	0.23	0.21	-0.28	0.54	-0.41	-0.32	0.18	-0.06	0.17
Total Operating Expenses	-0.01	0.02	0.0	0.94	0.08	-0.52	-0.51	-0.47	0.02		-0.23	0.02	-0.21	-0.33	0.08	-0.24	-0.23	-0.56	0.09	-0.46	0.24	0.35	0.08	-0.41	0.11	-0.51
Income Before Tax	0.08	-0.5	-0.02	-0.11	-0.12	0.39	0.39	0.37	-0.11	-0.23		0.87	0.99	0.87	-0.09	-0.08	0.98	0.1	-0.47	0.78	-0.58	0.4	0.82	0.42	0.44	0.23
Total Other Income Expense Net	-0.22	-0.54	-0.34	-0.01	-0.37	-0.1	-0.1	-0.12	-0.39	0.02	0.87		0.92	0.55	-0.35	0.08	0.93	-0.22	-0.34	0.55	-0.57	0.6	0.9	0.06	0.4	-0.11
Net Income	0.03	-0.48	-0.07	-0.11	-0.16	0.3	0.3	0.28	-0.15	-0.21	0.99	0.92		0.8	-0.13	-0.04	0.99	0.05	-0.42	0.73	-0.56	0.43	0.85	0.34	0.44	0.15
Income Tax Expense	0.23	-0.47	0.22	-0.09	0.07	0.71	0.71	0.68	0.1	-0.33	0.87	0.55	0.8		0.07	-0.21	0.77	0.31	-0.62	0.86	-0.55	0.19	0.55	0.66	0.39	0.5
Selling General Administrative	0.95	0.72	0.97	0.32	0.97	0.55	0.56	0.63	0.97	0.08	-0.09	-0.35	-0.13	0.07		-0.57	-0.21	0.29	0.23	-0.3	0.66	-0.46	-0.32	0.17	-0.11	0.19
Selling And Marketing Expenses	-0.42	-0.3	-0.63	-0.41	-0.63	-0.32	-0.33	-0.35	-0.62	-0.24	-0.08	0.08	-0.04	-0.21	-0.57		0.09	0.09	-0.07	0.28	-0.26	0.04	0.09	0.21	0.09	0.18
Net Income From Continuing Ops	-0.02	-0.53	-0.16	-0.16	-0.24	0.25	0.25	0.23	-0.24	-0.23	0.98	0.93	0.99	0.77	-0.21	0.09		0.06	-0.42	0.76	-0.6	0.44	0.86	0.37	0.45	0.18
Non Operating Income Net Other	0.32	0.3	0.28	-0.38	0.18	0.67	0.66	0.65	0.23	-0.56	0.1	-0.22	0.05	0.31	0.29	0.09	0.06		0.05	0.35	0.23	-0.78	-0.35	0.55	-0.33	0.76
Minority Interest	0.14	0.57	0.12	-0.01	0.22	-0.27	-0.27	-0.23	0.21	0.09	-0.47	-0.34	-0.42	-0.62	0.23	-0.07	-0.42	0.05		-0.6	0.64	-0.45	-0.43	-0.29	-0.42	-0.1
Tax Provision	-0.07	-0.68	-0.17	-0.32	-0.31	0.51	0.51	0.45	-0.28	-0.46	0.78	0.55	0.73	0.86	-0.3	0.28	0.76	0.35	-0.6		-0.71	0.2	0.56	0.77	0.42	0.59
Interest Income	0.5	0.92	0.49	0.27	0.55	-0.02	-0.02	0.04	0.54	0.24	-0.58	-0.57	-0.56	-0.55	0.66	-0.26	-0.6	0.23	0.64	-0.71		-0.67	-0.69	-0.28	-0.61	0.01
Net Interest Income	-0.38	-0.71	-0.4	0.25	-0.38	-0.4	-0.39	-0.41	-0.41	0.35	0.4	0.6	0.43	0.19	-0.46	0.04	0.44	-0.78	-0.45	0.2	-0.67		0.79	-0.19	0.72	-0.59
Discontinued Operations	-0.15	-0.68	-0.27	0.06	-0.3	-0.07	-0.06	-0.07	-0.32	0.08	0.82	0.9	0.85	0.55	-0.32	0.09	0.86	-0.35	-0.43	0.56	-0.69	0.79		0.17	0.76	-0.23
Reconciled Depreciation	0.41	-0.31	0.28	-0.17	0.14	0.74	0.73	0.72	0.18	-0.41	0.42	0.06	0.34	0.66	0.17	0.21	0.37	0.55	-0.29	0.77	-0.28	-0.19	0.17		0.36	0.83
Extraordinary Items	0.06	-0.64	-0.02	0.16	-0.05	0.08	0.09	0.09	-0.06	0.11	0.44	0.4	0.44	0.39	-0.11	0.09	0.45	-0.33	-0.42	0.42	-0.61	0.72	0.76	0.36		-0.22
Non Recurring	0.34	0.01	0.26	-0.3	0.13	0.72	0.7	0.69	0.17	-0.51	0.23	-0.11	0.15	0.5	0.19	0.18	0.18	0.76	-0.1	0.59	0.01	-0.59	-0.23	0.83	-0.22

Click cells to compare fundamentals

Mednax Account Relationship Matchups

Mednax income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	28.4M	32.1M	35.6M	36.2M	32.2M	32.7M
Interest Expense	110.5M	68.7M	39.7M	42.1M	40.7M	25.1M
Total Revenue	1.7B	1.9B	2.0B	2.0B	2.0B	1.5B
Gross Profit	449.3M	513.2M	467.0M	421.6M	2.0B	2.1B
Other Operating Expenses	1.6B	1.7B	1.8B	2.0B	2.1B	1.3B
Operating Income	173.5M	202.9M	172.7M	7.3M	(68.7M)	(65.3M)
Ebit	171.9M	217.7M	200M	(6.3M)	(60.6M)	(57.6M)
Ebitda	200.4M	249.9M	235.6M	29.9M	(28.4M)	(27.0M)
Cost Of Revenue	1.3B	1.4B	1.5B	1.6B	1.6B	1.0B
Total Operating Expenses	277.4M	295.5M	267.0M	414.2M	2.1B	2.2B
Income Before Tax	7.1M	135.2M	81.4M	(48.4M)	(101.3M)	(96.3M)
Total Other Income Expense Net	(91.0M)	(67.7M)	(91.3M)	(55.7M)	(32.6M)	(34.3M)
Net Income	(9.6M)	131.0M	66.3M	(60.4M)	(103.6M)	(98.4M)
Income Tax Expense	16.7M	27.2M	18.8M	12.0M	(2.3M)	(2.2M)
Selling General Administrative	248.9M	263.4M	231.4M	227.5M	238.4M	229.3M
Net Income Applicable To Common Shares	(1.5B)	(796.5M)	131.0M	66.3M	59.7M	48.1M
Net Income From Continuing Ops	(9.6M)	108.0M	62.6M	(60.4M)	(99.1M)	(94.1M)
Tax Provision	16.7M	27.2M	18.8M	12.0M	(2.3M)	(2.2M)
Interest Income	105.9M	91.0M	53.2M	34.3M	39.4M	69.6M
Net Interest Income	(110.5M)	(68.7M)	(39.7M)	(42.1M)	(40.7M)	(42.8M)
Discontinued Operations	(1.5B)	(786.9M)	23.0M	3.8M	3.4M	3.6M
Reconciled Depreciation	28.4M	32.1M	35.6M	36.2M	32.2M	45.8M
Extraordinary Items	(347.6M)	(786.9M)	23.0M	3.8M	3.4M	3.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

How To Invest In Mednax

Details

Is Mednax Stock a good investment?

Details

What is Mednax's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.11)

Earnings Share

(1.19)

Revenue Per Share

24.156

Quarterly Revenue Growth

0.012

Return On Assets

0.0525

The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mednax Historical Income Statement

About Mednax Income Statement Analysis

Mednax Income Statement Chart

Total Revenue

Other Operating Expenses

Minority Interest

Mednax income statement Correlations

Mednax Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Mednax income statement Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Cost Of Revenue	+ 0.99	Total Revenue
Ebitda	+ 0.99	Operating Income
Net Income	+ 0.99	Income Before Tax

Net Interest Income	- 0.78	Non Operating Income Net Other
Interest Income	- 0.71	Tax Provision
Net Interest Income	- 0.71	Interest Expense
Discontinued Operations	- 0.69	Interest Income
Discontinued Operations	- 0.68	Interest Expense
Tax Provision	- 0.68	Interest Expense